Systemically healthy periodontitis patients were recruited in this single-blind, split-mouth, randomized controlled clinical trial. After SRP, PDT was applied at probing depth (PD) ≥ 4 mm at test quadrant. At baseline, 3rd month and 6th month, clinical parameters and cytokine pattern in gingival crevicular fluids (GCFs) were analysed.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Changes from baseline probing depth at 3rd month and 6th month
Timeframe: 3 months and 6 months
Changes from baseline clinical attachment level at 3rd month and 6th month
Timeframe: 3 months and 6 months
Changes from baseline gingival recession level at 3rd month and 6th month
Timeframe: 3 months and 6 months
Changes from baseline bleeding score at 3rd month and 6th month
Timeframe: 3 months and 6 months
Changes from baseline Interleukin-1 level at 3rd month and 6th month
Timeframe: 3 months and 6 months
Changes from baseline Interleukin-6 level at 3rd month and 6th month
Timeframe: 3 months and 6 months
Changes from baseline Interleukin-8 level at 3rd month and 6th month
Timeframe: 3 months and 6 months
Changes from baseline Tumour necrosis factor-alpha level at 3rd month and 6th month
Timeframe: 3 months and 6 months
Changes from baseline Matrix metalloproteinase-8 level at 3rd month and 6th month
Timeframe: 3 months and 6 months